浏览全部资源
扫码关注微信
纸质出版日期:2022,
扫 描 看 全 文
胡高波, 朱瑞, 金湛, 等. 冬凌草甲素逆转乳腺癌MCF-7细胞对氟维司群耐药的机制研究[J]. 中国药房, 2022,33(17).
HU Gaobo, ZHU Rui, JIN Zhan, et al. Study on the mechanism of oridonin to reverse drug resistance of breast cancer cell MCF- 7 to fulvestrant[J]. China Pharmacy, 2022,33(17).
目的 探究冬凌草甲素(Ori)逆转乳腺癌MCF-7细胞对氟维司群(Ful)耐药的机制。方法在体外诱导构建乳腺癌获得性Ful耐药细胞株MCF-7/Ful;采用MTT法检测MCF-7细胞和MCF-7/Ful细胞的相对细胞活力,Ori对MCF-7/Ful细胞的抑制率;采用CompuSyn软件分析Ori和Ful的协同效应;将MCF-7/Ful细胞随机分为空白对照组、Ful组(5μmol/L)、Ori组(8μmol/L)、Ful(5μmol/L)+Ori(8μmol/L)组,采用Westernblot法检测各组细胞中磷脂酰肌醇-3-激酶(PI3K)/蛋白激酶B(Akt)信号通路相关蛋白的磷酸化情况。采用MCF-7/Ful细胞制备裸鼠移植瘤耐药模型,随机分为空白对照组、Ful组(80μmol/g)、Ori组(50μmol/g)、Ful(80μmol/g)+Ori(50μmol/g)组,计算肿瘤质量和抑瘤率,验证Ori在体内的耐药逆转作用。结果MTT法检测结果显示,当Ful≥10μmol/L时,MCF-7/Ful细胞的相对细胞活力显著高于MCF-7细胞(P<0.05),耐药性显著增强;Ori对MCF-7/Ful细胞具有明显的抑制作用,与Ful联合使用对MCF-7/Ful细胞的抑制率显著升高(P<0.05或P<0.01),逆转耐药效果显著增加。Westernblot法检测结果显示,与Ful组比较,Ful+Ori组细胞中PI3K、Akt磷酸化水平均显著降低(P<0.05或P<0.01)。体内实验结果显示,Ful+Ori组裸鼠的肿瘤体积和质量显著下降,抑瘤率为(63.90±4.11)%,较Ful组显著升高(P<0.01)。结论Ori可以逆转乳腺癌MCF-7细胞对Ful的耐药性,此作用可能是通过调控PI3K/Akt信号通路实现的。
OBJECTIVE To explore the mechanism of oridon in(Ori)reversing the drug resistance of breast cancer cell MCF-7 to fulvestrant (Ful). METHODS Ful-resistant breast cancer cell strains MCF- 7/Ful were induced and constructed in vitro . The relative cell viability of MCF- 7 cells and MCF- 7/Ful cells was detected by MTT assay ,inhibitory rate of Ori to MCF- 7/Ful cells was also detected. CompuSyn software was used to analyze the synergistic effect of Ori and Ful. MCF- 7/Ful cells were randomly divided into blank control group ,Ful group (5 μmol/L),Ori group (8 μmol/L),Ful(5 μmol/L)+Ori(8 μmol/L)group. The phosphorylation of phosphatidylinositol 3 kinase(PI3K)/protein kinase B (Akt)signaling pathway related protein in each group was detected by Western blot. MCF-7/Ful cells were used to prepare drug resistance model of transplanted tumor in nude mice,and they were randomly divided into blank control group ,Ful group (80 μmol/g),Ori group (50 μmol/g),Ful(80 μmol/g)+ Ori(50 μmol/g)group. The tumor weight and tumor inhibition rate were calculated ,to verify the reversal effect of Ori and Ful in vivo. RESULTS MTT assay showed that when Ful ≥10 μmol/L,the relative cell viability of MCF- 7/Ful cells was significantly higher than that of MCF- 7 cells(P<0.05),and the drug resistance was significantly enhanced ;Ori had a significant inhibitory effect on MCF- 7/Ful cells ,the inhibition rate of Ori combined with Ful to MCF- 7/Ful cells was significantly increased (P<0.05 or P<0.01),and the effect of reversing drug resistance was significantly increased . The results of Western blot showed that compared with Ful group ,the phosphorylation levels of PI 3K and Akt protein in Ful+Ori group were significantly decreased (P<0.05 or P< 0.01). In vivo results showed that the tumor volume and mass of Ful+Ori group were significantly decreased ,and the tumor inhibition rate was (63.90±4.11)%,which was significantly higher than that of Ful group (P<0.01). CONCLUSIONS Ori can reverse drug resistance of breast cancer cell MCF- 7 to Ful , and this effect may be through regulating PI 3K/Akt signaling pathway.
冬凌草甲素氟维司群磷脂酰肌醇-3-激酶/蛋白激酶B信号通路乳腺癌耐药逆转
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构